TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Brief Summary: The purpose of the study is to assess the benefits and risks of once-weekly dulaglutide compared to once-daily liraglutide in participants with type 2 diabetes who have inadequate glycemic control on metformin.


Options:
A: Arm Label: 1.5 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Metformin | Arm Label: Liraglutide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Liraglutide, Drug: Metformin | Intervention Type: DRUG; Name: LY2189265; Assigned to Arm(s): 1.5 mg LY2189265 | Intervention Type: DRUG; Name: Liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1.5 mg LY2189265, Liraglutide
B: Arm Label: Sitagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sitagliptin | Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: BI 10773 X mg; Type: EXPERIMENTAL; Interventions: Drug: BI 10773 | Arm Label: BI 10773 Y mg; Type: EXPERIMENTAL; Interventions: Drug: BI 10773 | Intervention Type: DRUG; Name: BI 10773; Assigned to Arm(s): BI 10773 Y mg | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: BI 10773; Assigned to Arm(s): BI 10773 X mg | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Sitagliptin
C: Arm Label: metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: gastric banding; Type: EXPERIMENTAL; Interventions: Device: gastric banding | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): metformin | Intervention Type: DEVICE; Name: gastric banding; Assigned to Arm(s): gastric banding
D: Arm Label: 1.5 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Metformin, Drug: Pioglitazone | Arm Label: 0.75 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Metformin, Drug: Pioglitazone | Arm Label: Exenatide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Exenatide, Drug: Metformin, Drug: Pioglitazone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: LY2189265, Drug: Placebo, Drug: Metformin, Drug: Pioglitazone | Intervention Type: DRUG; Name: LY2189265; Assigned to Arm(s): 0.75 mg LY2189265, 1.5 mg LY2189265, Placebo | Intervention Type: DRUG; Name: Exenatide; Assigned to Arm(s): Exenatide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 0.75 mg LY2189265, 1.5 mg LY2189265, Exenatide, Placebo | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): 0.75 mg LY2189265, 1.5 mg LY2189265, Exenatide, Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial to Determine the Effectiveness of Trauma Focused Cognitive Behavioral (TF-CBT) Among Children in Lusaka, Zambia
Brief Summary: The purpose of this study is to study the effectiveness of Trauma Focused Cognitive Behavioral Therapy in subset of children who are affected by trauma with significant mental health symptomatology in order to 1) examine the effectiveness of TF-CBT in reducing the severity of mental health symptoms experienced by traumatized children and adolescents in Lusaka and 2) determine the effectiveness of TF-CBT in reducing HIV risk taking behaviors and increasing coping strategies and health promotion activities in traumatized children and adolescents in Lusaka. The study will be integrated into current programing of the Serenity Harm Reduction Programme, a community and faith based organization focusing on mental health and substance use prevention and treatment, and its partners in 5 compounds.


Options:
A: Arm Label: Family-Focused Psychosocial Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention; Assigned to Arm(s): Family-Focused Psychosocial Intervention
B: Arm Label: Emotion Regulation Group Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Skills training of Affect-Regulation - A culture-sensitive approach: STARK | Arm Label: Wait List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Skills training of Affect-Regulation - A culture-sensitive approach: STARK; Assigned to Arm(s): Emotion Regulation Group Therapy
C: Arm Label: Step-by-Step; Type: EXPERIMENTAL; Interventions: Behavioral: Step-by-Step | Arm Label: Enhanced care as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced care as usual | Intervention Type: BEHAVIORAL; Name: Step-by-Step; Assigned to Arm(s): Step-by-Step | Intervention Type: BEHAVIORAL; Name: Enhanced care as usual; Assigned to Arm(s): Enhanced care as usual
D: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial to Determine the Effectiveness of Trauma Focused Cognitive Behavioral (TF-CBT) Among Children in Lusaka, Zambia
Brief Summary: The purpose of this study is to study the effectiveness of Trauma Focused Cognitive Behavioral Therapy in subset of children who are affected by trauma with significant mental health symptomatology in order to 1) examine the effectiveness of TF-CBT in reducing the severity of mental health symptoms experienced by traumatized children and adolescents in Lusaka and 2) determine the effectiveness of TF-CBT in reducing HIV risk taking behaviors and increasing coping strategies and health promotion activities in traumatized children and adolescents in Lusaka. The study will be integrated into current programing of the Serenity Harm Reduction Programme, a community and faith based organization focusing on mental health and substance use prevention and treatment, and its partners in 5 compounds.


Options:
A: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group
B: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling
C: Arm Label: TF-CBT; Type: EXPERIMENTAL; Interventions: Behavioral: TF-CBT | Arm Label: Waiting List control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: TF-CBT; Assigned to Arm(s): TF-CBT
D: Arm Label: BF-CBT and group physiotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: BF-CBT and group physiotherapy | Arm Label: Waiting list; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BF-CBT and group physiotherapy | Intervention Type: BEHAVIORAL; Name: BF-CBT and group physiotherapy; Assigned to Arm(s): BF-CBT and group physiotherapy, Waiting list

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial to Determine the Effectiveness of Trauma Focused Cognitive Behavioral (TF-CBT) Among Children in Lusaka, Zambia
Brief Summary: The purpose of this study is to study the effectiveness of Trauma Focused Cognitive Behavioral Therapy in subset of children who are affected by trauma with significant mental health symptomatology in order to 1) examine the effectiveness of TF-CBT in reducing the severity of mental health symptoms experienced by traumatized children and adolescents in Lusaka and 2) determine the effectiveness of TF-CBT in reducing HIV risk taking behaviors and increasing coping strategies and health promotion activities in traumatized children and adolescents in Lusaka. The study will be integrated into current programing of the Serenity Harm Reduction Programme, a community and faith based organization focusing on mental health and substance use prevention and treatment, and its partners in 5 compounds.


Options:
A: Arm Label: Trauma-Focused Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma-Focused Cognitive Behavioral Therapy | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trauma-Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Trauma-Focused Cognitive Behavioral Therapy
B: Arm Label: Child, Parenting, & Parent Web-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Bounce Back Now Website | Arm Label: Child & Parenting Web-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Bounce Back Now Website | Arm Label: Child & Parent Web-based Assessment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Bounce Back Now Website; Assigned to Arm(s): Child & Parenting Web-Intervention, Child, Parenting, & Parent Web-Intervention
C: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma-focused cognitive behavioral therapy (TF-CBT) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Child-centered supportive therapy (CCT) | Intervention Type: BEHAVIORAL; Name: Trauma-focused cognitive behavioral therapy (TF-CBT); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Child-centered supportive therapy (CCT); Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial to Determine the Effectiveness of Trauma Focused Cognitive Behavioral (TF-CBT) Among Children in Lusaka, Zambia
Brief Summary: The purpose of this study is to study the effectiveness of Trauma Focused Cognitive Behavioral Therapy in subset of children who are affected by trauma with significant mental health symptomatology in order to 1) examine the effectiveness of TF-CBT in reducing the severity of mental health symptoms experienced by traumatized children and adolescents in Lusaka and 2) determine the effectiveness of TF-CBT in reducing HIV risk taking behaviors and increasing coping strategies and health promotion activities in traumatized children and adolescents in Lusaka. The study will be integrated into current programing of the Serenity Harm Reduction Programme, a community and faith based organization focusing on mental health and substance use prevention and treatment, and its partners in 5 compounds.


Options:
A: Arm Label: Intervention Program of Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient Education and Behavioral Activation, Behavioral: Supporting Self-Care (care coordinators), Other: Psychiatrist and Diabetologist Reviews, Other: Decision-support Electronic Health Record System | Arm Label: Control Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard of Care | Intervention Type: BEHAVIORAL; Name: Patient Education and Behavioral Activation; Assigned to Arm(s): Intervention Program of Care | Intervention Type: BEHAVIORAL; Name: Supporting Self-Care (care coordinators); Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Psychiatrist and Diabetologist Reviews; Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Decision-support Electronic Health Record System; Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Control Arm
B: Arm Label: NET; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Exposure Therapy | Arm Label: AC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Academic Counseling | Arm Label: WL; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Narrative Exposure Therapy; Assigned to Arm(s): NET | Intervention Type: BEHAVIORAL; Name: Academic Counseling; Assigned to Arm(s): AC
C: Arm Label: Self Help Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Self Help Plus | Arm Label: Enhanced Treatment As Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self Help Plus; Assigned to Arm(s): Self Help Plus
D: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
Brief Summary: The purpose of this study is to evaluate the efficacy of risperidone compared with placebo in children and adolescents with irritability associated with autistic disorder.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: secretin, synthetic porcine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: secretin, biologically derived porcine; Assigned to Arm(s): N/A
C: Arm Label: Risperidone; Type: EXPERIMENTAL; Interventions: Drug: Risperidone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): Risperidone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: risperidone plus parent management training; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risperidone, Behavioral: Behavior Therapy | Arm Label: risperidone only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risperidone | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): risperidone only, risperidone plus parent management training | Intervention Type: BEHAVIORAL; Name: Behavior Therapy; Assigned to Arm(s): risperidone plus parent management training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
Brief Summary: The purpose of this study is to evaluate the efficacy of risperidone compared with placebo in children and adolescents with irritability associated with autistic disorder.


Options:
A: Arm Label: Trichuris Suis Ova (TSO); Type: EXPERIMENTAL; Interventions: Drug: Trichuris Suis Ova | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Trichuris Suis Ova | Intervention Type: DRUG; Name: Trichuris Suis Ova; Assigned to Arm(s): Placebo, Trichuris Suis Ova (TSO)
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: olanzapine (Zyprexa) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: olanzapine (Zyprexa); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): N/A
D: Arm Label: Risperidone; Type: EXPERIMENTAL; Interventions: Drug: Risperidone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): Risperidone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
Brief Summary: The purpose of this study is to evaluate the efficacy of risperidone compared with placebo in children and adolescents with irritability associated with autistic disorder.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vasopressin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vasopressin | Intervention Type: DRUG; Name: Vasopressin; Assigned to Arm(s): Vasopressin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Extended-release guanfacine; Type: EXPERIMENTAL; Interventions: Drug: extended-release guanfacine | Arm Label: Inactive placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Inactive placebo | Intervention Type: DRUG; Name: extended-release guanfacine; Assigned to Arm(s): Extended-release guanfacine
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: olanzapine (Zyprexa) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: olanzapine (Zyprexa); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: Risperidone; Type: EXPERIMENTAL; Interventions: Drug: Risperidone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): Risperidone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Brief Summary: The purpose of the study is to target inflammation to reduce progression of noncalcified plaque in the coronary arteries using omega-3 fatty acid supplementation compared to standard of care.


Options:
A: Arm Label: Aspirin + Omega-3 Ethyl Esters; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin, Drug: Omega-3 Ethyl Esters | Arm Label: Aspirin + Placebo Omega-3 Ethyl Esters; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin, Drug: Placebo Omega-3 Ethyl Esters | Arm Label: Placebo Aspirin + Omega-3 Ethyl Esters; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omega-3 Ethyl Esters, Drug: Placebo Aspirin | Arm Label: Placebo Aspirin + Placebo Omega-3 Ethyl Esters; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo Aspirin, Drug: Placebo Omega-3 Ethyl Esters | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin + Omega-3 Ethyl Esters, Aspirin + Placebo Omega-3 Ethyl Esters | Intervention Type: DRUG; Name: Omega-3 Ethyl Esters; Assigned to Arm(s): Aspirin + Omega-3 Ethyl Esters, Placebo Aspirin + Omega-3 Ethyl Esters | Intervention Type: DRUG; Name: Placebo Aspirin; Assigned to Arm(s): Placebo Aspirin + Omega-3 Ethyl Esters, Placebo Aspirin + Placebo Omega-3 Ethyl Esters | Intervention Type: DRUG; Name: Placebo Omega-3 Ethyl Esters; Assigned to Arm(s): Aspirin + Placebo Omega-3 Ethyl Esters, Placebo Aspirin + Placebo Omega-3 Ethyl Esters
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: omega-3 | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: omega-3, Behavioral: multi-domain intervention | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: multi-domain intervention, Drug: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: omega-3; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: multi-domain intervention; Assigned to Arm(s): 2, 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3, 4
C: Arm Label: OMEGA-3; Type: ACTIVE_COMPARATOR; Interventions: Drug: OMEGA-3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo soybean oil | Intervention Type: DRUG; Name: OMEGA-3; Assigned to Arm(s): OMEGA-3 | Intervention Type: DRUG; Name: Placebo soybean oil; Assigned to Arm(s): Placebo
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lovaza (Omega 3 ethyl esters); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega 3 acid ethyl esters | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega 3 acid ethyl esters; Assigned to Arm(s): Lovaza (Omega 3 ethyl esters)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of an Employee Wellness Programme in Clothing/Textile Manufacturing Companies: A Randomised Control Trial
Brief Summary: The introduction of a wellness programme for workers employed in a clothing factory will improve quality of life, pain, attendance at work and levels of physical activity.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Employee wellness programme | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comparator (Once off educational session and educational materials) | Intervention Type: BEHAVIORAL; Name: Employee wellness programme; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Comparator (Once off educational session and educational materials); Assigned to Arm(s): Control group
B: Arm Label: Multi-component lifestyle intervention 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Multi-component lifestyle intervention | Arm Label: Multi-component lifestyle intervention 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Multi-component lifestyle intervention | Arm Label: Multi-component lifestyle intervention 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Multi-component lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Multi-component lifestyle intervention; Assigned to Arm(s): Multi-component lifestyle intervention 1, Multi-component lifestyle intervention 2, Multi-component lifestyle intervention 3
C: Arm Label: Move; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Move | Arm Label: Stand & Move; Type: EXPERIMENTAL; Interventions: Device: Sit-Stand workstation, Behavioral: Move | Intervention Type: DEVICE; Name: Sit-Stand workstation; Assigned to Arm(s): Stand & Move | Intervention Type: BEHAVIORAL; Name: Move; Assigned to Arm(s): Move, Stand & Move
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention

Answer: A